The Role of Autophagy in Acute Myocardial Infarction
- 1Department of Internal Medicine, The WuYun Mountain Sanatorium of Hangzhou, Hangzhou, China
- 2Department of Cardiology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China
Acute myocardial infarction refers to a sudden death of cardiomyocytes, which leads to a large mortality worldwide. To attenuate acute myocardial infarction, strategies should be made to increase cardiomyocyte survival, improve postinfarcted cardiac function, and reverse the process of cardiac remodeling. Autophagy, a pivotal cellular response, has been widely studied and is known to be involved in various kinds of diseases. In the recent few years, the role of autophagy in diseases has been drawn increasing attention to by researchers. Here in this review, we mainly focus on the discussion of the effect of autophagy on the pathogenesis and progression of acute myocardial infarction under ischemic and ischemia/reperfusion injuries. Furthermore, several popular therapeutic agents and strategies taking advantage of autophagy will be described.
Acute myocardial infarction, also well known as acute heart attack, is induced by the sudden blockade or occlusion of a major branch of a coronary artery, thus leading to the ischemia or infarct of cardiomyocytes (Stanley, 2001; Klopsch et al., 2019; Musher et al., 2019). So far, it is generally acknowledged that at 12 h or a little later after the onset of irreversible ischemia, the earliest change is observed morphologically as pallor of the myocardium, referring to the ischemia of cardiomyocytes (Burke and Virmani, 2007; Li et al., 2019; Shoji et al., 2019). The disturbance of blood flow leads to the deprivation of energy supply, which results in the dysfunction and death of cardiomyocytes (Burke and Virmani, 2007). The cardiac damage of acute myocardial infarction is widely acknowledged via the ischemic and ischemia/reperfusion injuries, thus resulting in the detrimental effect on cardiomyocytes as well as cardiac functions. The mechanisms of myocardial injury under irreversible ischemic stress included increased cytosolic Ca2+ induced by the inhibition of Na+, K+-ATPase and disturbance of mitochondria, leading to the activation of various kinds of proteases, cleavage of anchoring cytoskeletal proteins, and progressive increases in cell membrane permeability (Jennings and Ganote, 1974; Jennings et al., 1995; Stanley, 2001; Buja, 2005; Burke and Virmani, 2007). Consequently, protecting cardiomyocytes against ischemic injury serves as a vital strategy for the treatment of acute myocardial infarction. Furthermore, the infiltration of inflammatory cells such as macrophages and neutrophils has been observed in the border areas on the occurrence of acute myocardial infarction, indicating that suppression of inflammatory reaction in cardiac ischemic regions also provides a potential and effective pathway (Crea and Libby, 2017; Loyer et al., 2018; Ong et al., 2018; Zhang et al., 2018a; Peng et al., 2019). So far, although increasing knowledge has been gained on acute myocardial infarction and various kinds of interventions have been developed, the gross mortality of acute myocardial infarction patients remains high, and more effective therapeutic strategies are still demanded.
Autophagy is a vital metabolic process for the degradation of senescent or damaged proteins and organelles into amino acids and fatty acids for energy production and recycling (Catana et al., 2018; Wang et al., 2018c). It is activated in response to nutrient starvation or metabolic stress for the maintenance of tissue functions and homeostasis (Dong et al., 2018). It has been demonstrated that basal autophagy is vital for the maintenance of normal cardiac functions (Zhang et al., 2018b). Under the ischemic stress, autophagy is activated to protect cardiomyocytes against ischemic or ischemia/reperfusion injury (Sciarretta et al., 2014; Wang et al., 2018b). Furthermore, autophagy can act as an inflammatory suppressor, thus contributing to the alleviation of progress of cardiac injury (Mohajeri and Sahebkar, 2018; Ryter et al., 2018; Li et al., 2018c). However, excessive activation of autophagy may lead to a detrimental effect on the heart in the reperfusion damage as well as other stress conditions, indicating the controversial effect of autophagy in cardiac ischemia (Ma et al., 2011; Bai et al., 2018). Here in this paper, we will discuss the role of autophagy in acute myocardial infarction in the alleviation of myocardial infarction under the ischemic and ischemia/reperfusion injuries. Furthermore, several potential and effective therapeutic strategies taking advantage of autophagy will be discussed, aiming to provide insights in the development of new drugs or therapies against acute myocardial infarction.
Biology of Autophagy
The word “autophagy,” derived from Greek roots “auto” (self) and “phagy” (eat), was initially created by Dr. Christian de Duve in 1960s, referring to a cellular catabolic process in which intracellular substances were degraded by itself (Klionsky et al., 2016; Ktistakis, 2017). Recently, Dr. Yoshinori Ohsumi was awarded the 2016 Nobel Prize in Medicine or Physiology for his discovery of cellular autophagy processes, which made a big step in the development of novel therapies for various kinds of diseases taking advantage of autophagy (Van Noorden and Ledford, 2016; Harnett et al., 2017). So far, it has been widely acknowledged that autophagy is a vital catabolic mechanism relying on lysosomes (Hewitt and Korolchuk, 2017). During the autophagy process, some long-lived or misfolded proteins as well as damaged organelles are transferred into lysosomes for degradation into fundamental nutrient substance such as amino acids for recycling and further use (Boya et al., 2018; Li et al., 2018b). According to the patterns of cargo delivery to the lysosomal lumen and physiological functions, autophagy has been mainly classified into three types, namely macroautophagy, microautophagy, and chaperone-mediated autophagy (Zhang et al., 2018c). Macroautophagy is a catabolic process characterized by sequestration of cytoplasmic material in double membrane vacuoles called autophagosomes, which are then delivered to the lysosome for degradation (Wang et al., 2018c). Microautophagy is a non-selective lysosomal degradative process referring to the engulfment of cytoplasmic constituents through invagination of the lysosomal/vacuolar membranes (Kalachev and Yurchenko, 2017). Chaperone-mediated autophagy is a type of autophagy that allows the degradation of cytosolic proteins depending on chaperones. It is recognized as the only autophagy process that allows selective degradation of soluble cytosolic proteins in lysosomes (Alfaro et al., 2018). In addition to those three kinds of classic autophagy, some special forms of autophagy (selective autophagy) have been described, including mitophagy, pexophagy, ribophagy, xenophagy, and secretory autophagy (Ponpuak et al., 2015; Mao and Klionsky, 2017; An and Harper, 2018; Broda et al., 2018; Tsuchiya et al., 2018). Since macroautophagy is the most extensively studied form of autophagy, here in this review, the role of macroautophagy in acute myocardial infarction will be discussed (hereafter referred to as “autophagy”).
Autophagy process is an evolutionarily conserved process from yeast to mammals (Schultz et al., 2017). So far, more than 30 kinds of autophagy-related genes (Atgs) proteins are recognized to be involved in the process of autophagy (Diaz et al., 2017; Wildenberg et al., 2017). Generally speaking, autophagy is performed in two major steps (Bento et al., 2016; Shao et al., 2016; Zachari and Ganley, 2017; Wang et al., 2018c). In the first step, the Unc-51-like kinase 1 (ULK1), focal adhesion kinase family interacting protein of 200 kD (FIP200), Atg13, and Atg101 are combined to form the Atg1 complex, which subsequently triggers the assembly of Beclin-1, Atg14, VSP15, and VSP34 comprising the Class III phosphatidylinositol 3-hydroxy kinase (PI3K) complex. The Class III PI3K complex leads to the membrane nucleation process and formation of the cup-shaped, lipid bilayer membrane-structured phagophore. Further membrane expansion and fusion together with the Atg5-Atg12-Atg16L1 and light chain 3 (LC3) result in the occurrence of the intracellular, spherical double-membraned autophagosomes enclosing proteins and organelles. In the second step, with the disposal of “coat proteins” (LC3-II) on the surface, autophagosomes integrate with lysosomes to form the single membrane-structured autolysosomes, the functional units of autophagy for degradation and recycling.
So far, among the whole complicated signaling network of autophagy, two classical signaling pathways have been described for the inhibitory and promoted regulation of autophagy (Inoki et al., 2012; Shao et al., 2016). The Class I PI3K-mammalian target of rapamycin (mTOR) signaling pathway, a classical inhibitory pathway, is triggered in the presence of nutrient enrichment, to stimulate the activation of mTOR and the mTOR complex (mTORC1) via protein kinase B (Akt) pathway, thus inhibiting the formation of the Atg1 complex (Kaur and Sharma, 2017; Perez-Alvarez et al., 2018). The other classical signaling pathway of autophagy is induced by AMP-activated protein kinase (AMPK), a sensor of stress and nutrient input, which promotes the occurrence of autophagy process through activating the ULK1 kinase complex by inactivating mTORC1 or phosphorylating ULK1 at various serine residues (Dodson et al., 2013; Zhao et al., 2018a). So far, several kinds of agents have been developed for the blockade or induction of autophagy in different mechanisms, such as rapamycin, chloroquine, bafilomycin A1, and 3-methyladenine (3-MA), thus largely facilitating the fundamental study of autophagy (Germic et al., 2017; Bhat et al., 2018; Zhao et al., 2018b).
It has been widely reported that the induction of autophagy in a moderate extent plays a protective role in organisms. For instance, autophagy has been demonstrated to inhibit apoptosis in various kinds of cells (Pott et al., 2018; Wang et al., 2018a). It has also been reported that autophagy contributes to the suppression of inflammatory and immune reaction in many kinds of inflammation-related disorders (Burger et al., 2018; Pankratz et al., 2018; Chen et al., 2019; Gogiraju et al., 2019). Autophagy has been shown to be vital in the inhibition of the pathogenesis and progression of various kinds of diseases in the central nervous system (ischemic stroke, multiple sclerosis, Alzheimer’s disease), cardiovascular system (myocardial infarction, heart failure, atherosclerosis), endocrine system (diabetes, obesity), digestive system (inflammatory bowel disease), and so on (Crino, 2016; Cosin-Roger et al., 2017; Schwerd et al., 2017; Zhao et al., 2017; Lambelet et al., 2018; Liu et al., 2018c; Sciarretta et al., 2018). However, it has also been noted that overinduction of the autophagy process might lead to the detrimental effect of cells, the so-called “autophagic cellular death” in organisms, indicating the importance of controlling the extent of autophagy induction in the treatment of diseases (Lambelet et al., 2018; Wang et al., 2018c).
Autophagy in Acute Myocardial Infarction
From our previous description, the acute myocardial infarction leads to the infarct or death of cardiomyocytes under the stress of ischemic or ischemia/reperfusion injury. As a result, to fight against acute myocardial infarction, strategies should be developed to protect cardiomyocytes against such injuries. In this section, the role of autophagy in cardioprotection will be discussed in the challenge of ischemic or ischemia/reperfusion injury. However, it has been demonstrated that overactivation of cardiac autophagy leads to a detrimental effect of acute myocardial infarction, which will also be discussed in the following contents.
Cardiac Autophagy in Ischemic Injury
Beneficial Effect of Cardiac Autophagy in Ischemic Injury
As we discussed above, autophagy is vital for the maintenance of cellular function and homeostasis for its degradation of long-lived proteins and damaged organelles to prevent protein aggregate accumulation to cytotoxic levels. Baseline autophagy or “adaptive” induction of autophagy produced a protective and alleviative role in ischemic injury.
Baseline autophagy is necessary in maintaining cardiac structure and function since impaired autophagy has been reported to contribute to the pathogenesis and progression of heart failure (Pattison and Robbins, 2008; Bhuiyan et al., 2013). For instance, it was demonstrated that depletion of Atg7 significantly increased the pathology in cardiomyocytes (Pattison et al., 2011). Ulk1-deleted mice showed exacerbation of lipotoxicity associated with retarded cardiac function and FIP200 and Atg13 were proven to be necessary for cardiac development during embryogenesis (Gan et al., 2006; Kaizuka and Mizushima, 2016; Ghosh and Pattison, 2018). Furthermore, it was demonstrated that genetic variants on chromosome 1p13.3 near the damage-regulated autophagy modulator 2 (DRAM2) gene were associated with non-ST elevation myocardial infarction in a case–control study (Salo et al., 2015). Those findings indicate the importance of autophagy in cardiac tissue. Autophagy was previously reported to be upregulated in patients with coronary artery disease or acute myocardial infarction compared to the healthy controls (Bullon et al., 2017; Demircan et al., 2018). In addition, it was demonstrated that the declination of autophagy and mitochondrial impairment led to impaired host response to hypoxic-ischemic injury, thus producing the detrimental effect of cardiomyocytes (Ham and Raju, 2017). In patients or animals with diabetes, hyperglycemia, or other metabolic derangements, cardiac function was detrimental because of the dysfunction of cardiac autophagy, indicating a future potential and effective therapeutic strategy in preserving cellular homeostasis and survival in patients with metabolic derangements (Baranyai et al., 2015; Sciarretta et al., 2015). Furthermore, mitophagy, a special form of autophagy functioning in the maintenance of mitochondrial homeostasis, has been considered to play as a cardioprotective under ischemic injury, indicating the important role of mitophagy in ischemic injury (Tahrir et al., 2019).
So far, autophagy has been widely reported to produce an alleviative effect in acute myocardial infarction. Some researchers reported that the “adaptive” induction of autophagy functioned in attenuation of aggregate/aggresome formation in heart, thus suppressing the detrimental effect of protein aggregation (Tannous et al., 2008). In addition, Aisa et al. (2017) reported that autophagy could reduce the infarct size of acute myocardial infarction after left anterior descending ligation in rat models. Similar conclusion was drawn by Kanamori et al. (2011), who showed that the administration of autophagy inhibitor, bafilomycin A1, significantly increased the infarct size of animal acute myocardial infarction models, indicating autophagy as an innate and potent process that produced a cardioprotective effect against ischemic injury during acute myocardial infarction. It was demonstrated that the autophagy process was upregulated through the AMPK-mTOR signaling pathway in cardiomyocytes, thus leading to the attenuation of acute myocardial infarction in animal models (Li et al., 2016, 2017; Foglio et al., 2017). It was also shown by Sciarretta et al. (2012) that genetic inhibition of AMPK signaling pathway led to the dysfunction of autophagy process, which resulted in the increase in infarct size in acute myocardial infarction. The phosphatase and tensin homolog deleted on chromosome 10 (PTEN)-PI3K-Akt signaling pathway was also demonstrated to be involved in the induction of cardiac autophagy in in vitro hypoxia (Zhang et al., 2017). Furthermore, Wu et al. (2014, 2017) demonstrated that upregulation of autophagy flux could protect cardiomyocytes against ischemia and attenuate adverse cardiac remodeling after acute myocardial infarction in rat models. The administration of autophagy inhibitor, 3-MA, contributed to adverse cardiac remodeling through the induction of nuclear factor-κB (NF-κB) activation in animal acute myocardial infarction models (Wu et al., 2014).
Detrimental Effect of Cardiac Autophagy in Ischemic Injury
As discussed above, baseline autophagy or autophagy induced in a proper extent produces a protective effect in ischemic injury through the maintenance of cellular homeostasis and degradation of organelles or misfolded proteins for ATP production in cardiomyocytes. However, it has been reported that under the condition of severe ischemia, the overwhelming induction of cardiac autophagy may promote cell death and worsen cardiac performance (Li et al., 2018a; Liu et al., 2018a; Xiao et al., 2018).
According to a previous study conducted by Lu et al. (2018), extensively induced autophagy was revealed to be detrimental in the severity of acute myocardial infarction in animal models, and exercise preconditioning was reported to reduce the high level of serum cTnI and severity of myocardial ischemia/hypoxia through the downregulation of excessive autophagy and cardiac KATP channels. In addition, transforming growth factor-β receptor I downregulation induced by loss of Sirt7, a kind of factor in response to acute myocardial infarction, was blocked by autophagy inhibitor, indicating that Sirt7 could maintain transforming growth factor receptor I via modulating autophagy in tissue repair process in response to ischemic injury (Araki et al., 2015).
In the occurrence of cardiac ischemia or infarction, hypoxia-induced injury serves as one of the major factors in cardiac damage through the induction of apoptosis and excessive autophagy process (Zhang et al., 2016). It has been demonstrated that the exosome-transported miRNA-93-5p produced a cardioprotective effect in the animal model of acute myocardial infarction as well as in an in vitro model of hypoxic H9C2 cells through the suppression of hypoxia-induced autophagy and inflammatory cytokine expression by targeting Atg7, a vital autophagy-related gene and Toll-like receptor 4 (Liu et al., 2018b). In addition, another microRNA, MicroRNA-223, was reported to protect neonatal rat cardiomyocytes and H9C2 cells from hypoxia-induced apoptosis and excessive autophagy through the Akt/mTOR pathway by targeting PARP-1 (Liu et al., 2018c). Taken together, those previous studies demonstrated the detrimental effect of hypoxia-induced excessive autophagy in the severity of acute myocardial infarction.
Cardiac Autophagy in Ischemia/Reperfusion Injury
Beneficial Effect of Cardiac Autophagy in Ischemia/Reperfusion Injury
As we discussed above, the “adaptive” induction of autophagy process, which is responsible for the degradation and recycling of proteins and organelles, is vital for the maintenance of cellular function under certain stress conditions. In myocardial ischemia/reperfusion, induction of autophagy in an adaptive manner contributes to the alleviation of cardiac damage under ischemia/reperfusion injury.
For instance, a positive association between pharmacological upregulation of autophagy and increased resistance to myocardial ischemia/reperfusion injury was demonstrated by Przyklenk et al. (2011) in an in vivo swine model of acute myocardial infarction, despite the fact that the induction of autophagy was either protective or detrimental of the severity of acute myocardial infarction in patients. Similar to the effect on cardiac ischemic injury, baseline autophagy produces a cardioprotective effect against ischemia/reperfusion injury. It was demonstrated that the impairment of autophagosome clearance mediated in part by reactive oxygen species-induced decline in lysosome-associated membrane protein-2 and upregulation of Beclin-1 under ischemia/reperfusion injury contributed to the enhancement of cardiomyocyte death (Ma et al., 2012). In addition, it was demonstrated that the quality control of mitophagy served as an effective pathway in the protective cardiomyocytes under ischemia/reperfusion injury via the maintenance of mitochondrial homoeostasis (Siasos et al., 2018). Those findings indicated that the restoration of baseline autophagy could serve as an effective and potential strategy in fighting against ischemia/reperfusion injury.
In addition, the protective effect of autophagy in cardiomyocytes against ischemia/reperfusion injury was also reported by several other researchers, indicating the alleviative role of autophagy in acute myocardial infarction (Sala-Mercado et al., 2010; Sengupta et al., 2011; DuSablon et al., 2017; Song et al., 2017; Fu et al., 2018). It was reported that the natural compound of visnagin delivered by nanoparticles induced cardioprotection, reducing the size of the acute myocardial infarction and ameliorating cardiac dysfunction through the induction of autophagy and thus leading to the inhibition of apoptosis process under ischemia/reperfusion injury (Fu et al., 2018). The proper induction of autophagy process could largely improve cell viability, contributing to the protection of cardiomyocytes (DuSablon et al., 2017). Taken together, those studies demonstrated the cardioprotective effect of autophagy induction in the prevention of ischemia/reperfusion damage.
Detrimental Effect of Cardiac Autophagy in Ischemia/Reperfusion Injury
As discussed above, baseline autophagy or adaptively induced cardiac autophagy plays a cardioprotective role under ischemia/reperfusion injury. However, attention should be paid to the development of therapeutic strategies against acute myocardial infarction taking advantage of upregulation of autophagy against ischemia/reperfusion injury. The autophagy process induced by several factors has been reported to be detrimental to cardiomyocytes.
For example, it was reported that ischemia/reperfusion-induced autophagy could lead to the cascade induction of apoptosis, necrosis, and inflammatory reaction, which led to the damage of cardiac cell viability (Qian et al., 2009). In addition, the NF-κB-induced autophagy was demonstrated to exacerbate myocardial injury in acute myocardial infarction, indicating the importance of the source of autophagy induction (Zeng et al., 2013, 2016). Furthermore, the excessive autophagy process induced by hypoxia was reported to lead to cardiac cell viability, which was reported to be possible to involve the PI3K/AKT/mTOR pathway (Qin et al., 2018).
In some conditions, the role of autophagy in acute myocardial infarction in the process of ischemia and reperfusion is controversial. For example, it was previously reported that mitochondrial aldehyde dehydrogenase (ALDH2), a kind of enzyme that catalyzes the oxidation of aldehydes, could significantly promote autophagy process during ischemia via the activation of AMPK and downregulation of mTOR, thus producing a cardioprotective effect. On the contrary, during the reperfusion process, ALDH2 could suppress the level of the autophagy process through the activation of Akt and mTOR, thus protecting cardiomyocytes against cell death in hypoxia and reoxygenation (Ma et al., 2011). Those findings indicated that attention should be paid to the development of therapies against acute myocardial infarction particularly for their potential controversial effects on ischemic and reperfusion conditions.
Pharmacological Intervention of Autophagy in the Treatment of Acute Myocardial Infarction
So far, an increasing number of fundamental and clinical studies have been conducted in the development of therapeutic strategies taking advantage of autophagy in the treatment of acute myocardial infarction. Fortunately, numerous promising autophagy inducers have been described, several of which will be briefly described below together with their pharmacological mechanisms (summarized in Table 1).
Table 1. Potential mechanisms of autophagy inducers in the treatment of acute myocardial infarction.
During acute myocardial infarction, apoptosis is widely considered to be involved in a large number of cardiomyocyte death as well as progressive loss of surviving cells in failing hearts (Takemura and Fujiwara, 2006). As a result, suppressing apoptosis in cardiomyocytes provides a potential and effective strategy in the alleviation of acute myocardial infarction. So far, several autophagy inducers have been reported to be effective in alleviating acute myocardial infarction taking advantage of apoptosis inhibition. For example, Liu et al. (2017) demonstrated that Apelin, the endogenous ligand for the G-protein-coupled APJ receptor, could suppress cardiac apoptosis via enhancement of autophagy, thus significantly decreasing myocardial infarction size and alleviating myocardial ischemia/reperfusion injury. Those effects were associated with the activation of Apelin/APJ system. It was also shown by Li et al. (2017) that Tongxinluo, a traditional Chinese medicine, produced a cardioprotective role against acute myocardial infarction via attenuating apoptosis in cardiomyocytes by inducing AMPK-mediated autophagy. Furthermore, human cellular repressor of E1A-stimulated genes (CREG), a secreted glycoprotein that regulated tissue and cell homeostasis, was reported to attenuate cardiac fibrosis after ischemia/reperfusion injury through the inhibition of apoptosis and enhancement of autophagy via regulation of lysosomal protein transfer, indicating a potential protective effect of CREG in myocardial infarction (Song et al., 2017). In addition, it was demonstrated that atorvastatin was involved in the regulation of apoptosis and autophagy process via the AMPK-mTOR signaling pathway, thus producing a cardioprotective role during acute myocardial infarction (Li et al., 2016).
MicroRNAs refer to small non-coding RNA molecules functioning in RNA silencing and post-transcriptional regulation of gene expression (Ambros, 2004). In acute myocardial infarction, an increasing number of microRNAs have been reported to be useful both as biomarkers for heart injury detection and therapeutics to overcome limitations of past strategies and treat the lesions (Paiva and Agbulut, 2017). Among several of them, their functions in acute myocardial infarction are involved in the induction of cardiac autophagy. For example, Zhang et al. (2017) demonstrated that knockdown of microRNA-122 protected cardiomyocytes against hypoxia injury via the induction of chromosome 10 (PTEN)-PI3K-Akt signaling-mediated autophagy, indicating that targeting microRNA-122 might be a potential therapeutic strategy in the treatment of acute myocardial infarction. Another microRNA, microRNA-30a, was also reported to be detrimental in the induction of the protective autophagy in cardiomyocytes under hypoxia, transferred through the secretion of exosomes in the serum of acute myocardial infarction patients, suggesting the therapeutic role of inhibiting microRNA-30a in acute myocardial infarction (Yang et al., 2016).
Besides those two classifications described above, several other autophagy inducers have opened up in the treatment of acute myocardial infarction. It has been reported that metformin, a biguanide often used in the treatment of diabetes, produced a favorable effect on left ventricular function after acute myocardial infarction regardless of glycemic control (Paneni et al., 2015). This cardioprotective effect was investigated to be involved in the induction of AMPK-mediated autophagy process (Paneni et al., 2015). In addition, berberine, a quaternary ammonium salt from the protoberberine group of benzylisoquinoline alkaloids, was shown to attenuate adverse left ventricular remodeling and improve cardiac function in acute myocardial infarction animal models through autophagy induction mediated by the activation of p38 MAPK inhibition and phosphor-Akt activation (Zhang et al., 2014).
Furthermore, rapamycin, a classic autophagy inducer, was also reported to contribute to the attenuation of cardiac remodeling and dysfunction after acute myocardial infarction through the suppression of the overactivated NF-κB-mediated inflammatory cascade, since the occurrence of acute myocardial infarction was reported to contribute to the overwhelming induction of inflammatory reaction (Wu et al., 2014). This cardioprotective effect was further proven by fluorescence molecular tomography in acute myocardial infarction patients (Chen et al., 2013). Another autophagy inducer, ginkgolide K, was demonstrated to reduce infarct size, rescue heart dysfunction, and ameliorate endoplasmic reticulum (ER) dilation through the enhancement of inositol-requiring enzyme 1α (IRE1α)/X box-binding protein-1 (XBP1) activity and increase of ER-associated degradation-mediated clearance of misfolded proteins and autophagy (Wang et al., 2016).
Besides those autophagy inducing agents, it is interesting to prove that taking exercise contributed to the attenuation of acute myocardial infarction through the improvement of cardiac autophagy flux (Campos et al., 2017). This protective effect was led to by reducing the mitochondrial number/size ratio as well as increasing mitochondrial bioenergetics and better cardiac function (Campos et al., 2017). As a result, taking exercise training was regarded as a potential and effective therapy against acute myocardial infarction (Tao et al., 2015).
The past decade has witnessed the increasing understanding of the biology of autophagy and its roles in various kinds of disorders. Here, we reviewed both the protective and detrimental effects of autophagy in the pathogenesis and progression of acute myocardial infarction under ischemic or ischemia/reperfusion injuries (illustrated in Figure 1). We demonstrated that baseline autophagy or adaptively induced autophagy contributed to the alleviation of ischemic or ischemia/reperfusion damage while overwhelmingly induction of autophagy was detrimental during acute myocardial infarction. In addition, several agents and therapeutics for the treatment of acute myocardial infarction taking advantage of autophagy were also summarized. Based on the previous studies on the issue of autophagy in acute myocardial infarction, so far, several strategies could be made in the regulation of autophagy induction, including controlling the doses of autophagy inducers and monitoring cardiac functions when applying agents taking advantage of autophagy or elution on stents after coronary angioplasty. However, since the mechanisms of autophagy in acute myocardial infarction are complicated, so far, no specific pathway through which autophagy could be properly induced to be protective in acute myocardial infarction while getting rid of the detrimental effects of autophagy was elucidated. As a result, to ultimately take advantage of autophagy in the treatment of autophagy, further studies are demanded.
Figure 1. Schematic illustration of the role of autophagy in acute myocardial infarction. On the occurrence of acute myocardial infarction, cardiomyocytes suffered from ischemic or ischemia/reperfusion injury. Baseline or adaptively induced autophagy contributes to the alleviation of acute myocardial infarction. However, overwhelming induction of autophagy plays a detrimental role in acute myocardial infarction. So far, several clarifications of agents or pathways taking advantage of maintaining the function of baseline autophagy or adaptively inducing autophagy have been reported to be effective in the alleviation of acute myocardial infarction. Those agents or pathways include several apoptosis inhibitors such as Apelin, Tongxinluo, CREG, and Atorvastatin; microRNAs including MicroRNA-122 and MicroRNA-30a; and other agents including metformin, berberine, rapamycin, ginkgolide K, and exercise. Because of the complication of the effects and mechanisms of autophagy in acute myocardial infarction, the specific pathways in taking advantage of autophagy to effectively attenuate acute myocardial infarction remain unclarified. Further studies are demanded on this issue.
DW and KZ analyzed concerned literatures and wrote the manuscript. PH revised the manuscript. All the authors agreed to be accountable for the content of the work.
This work was supported by grants from the Natural Science Foundation of Zhejiang Province (LY18H270008).
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Alfaro, I. E., Albornoz, A., Molina, A., Moreno, J., Cordero, K., Criollo, A., et al. (2018). Chaperone mediated autophagy in the crosstalk of neurodegenerative diseases and metabolic disorders. Front. Endocrinol. 9:778. doi: 10.3389/fendo.2018.00778
Araki, S., Izumiya, Y., Rokutanda, T., Ianni, A., Hanatani, S., Kimura, Y., et al. (2015). Sirt7 Contributes to myocardial tissue repair by maintaining transforming growth factor-beta signaling pathway. Circulation 132, 1081–1093. doi: 10.1161/CIRCULATIONAHA.114.014821
Bai, Y. D., Yang, Y. R., Mu, X. P., Lin, G., Wang, Y. P., Jin, S., et al. (2018). Hydrogen sulfide alleviates acute myocardial ischemia injury by modulating autophagy and inflammation response under oxidative stress. Oxid. Med. Cell. Longev. 2018:3402809. doi: 10.1155/2018/3402809
Baranyai, T., Nagy, C. T., Koncsos, G., Onodi, Z., Karolyi-Szabo, M., Makkos, A., et al. (2015). Acute hyperglycemia abolishes cardioprotection by remote ischemic perconditioning. Cardiovasc. Diabetol. 14:151. doi: 10.1186/s12933-015-0313-1
Bento, C. F., Renna, M., Ghislat, G., Puri, C., Ashkenazi, A., Vicinanza, M., et al. (2016). Mammalian autophagy: how does it work? Annu. Rev. Biochem. 85, 685–713. doi: 10.1146/annurev-biochem-060815-014556
Bhat, P., Kriel, J., Shubha Priya, B., Basappa,, Shivananju, N. S., and Loos, B. (2018). Modulating autophagy in cancer therapy: advancements and challenges for cancer cell death sensitization. Biochem. Pharmacol. 147, 170–182. doi: 10.1016/j.bcp.2017.11.021
Bhuiyan, M. S., Pattison, J. S., Osinska, H., James, J., Gulick, J., Mclendon, P. M., et al. (2013). Enhanced autophagy ameliorates cardiac proteinopathy. J. Clin. Invest. 123, 5284–5297. doi: 10.1172/JCI70877
Bullon, P., Cano-Garcia, F. J., Alcocer-Gomez, E., Varela-Lopez, A., Roman-Malo, L., Ruiz-Salmeron, R. J., et al. (2017). Could NLRP3-inflammasome be a cardiovascular risk biomarker in acute myocardial infarction patients? Antioxid. Redox Signal. 27, 269–275. doi: 10.1089/ars.2016.6970
Burger, E., Araujo, A., Lopez-Yglesias, A., Rajala, M. W., Geng, L., Levine, B., et al. (2018). Loss of Paneth cell autophagy causes acute susceptibility to Toxoplasma gondii-mediated inflammation. Cell Host Microbe 23, 177–190. e174. doi: 10.1016/j.chom.2018.01.001
Campos, J. C., Queliconi, B. B., Bozi, L. H. M., Bechara, L. R. G., Dourado, P. M. M., Andres, A. M., et al. (2017). Exercise reestablishes autophagic flux and mitochondrial quality control in heart failure. Autophagy 13, 1304–1317. doi: 10.1080/15548627.2017.1325062
Catana, C. S., Atanasov, A. G., and Berindan-Neagoe, I. (2018). Natural products with anti-aging potential: affected targets and molecular mechanisms. Biotechnol. Adv. 36, 1649–1656. doi: 10.1016/j.biotechadv.2018.03.012
Chen, Z., Li, C., Qian, Y. H., Fu, Y., and Feng, Z. M. (2019). Enhancement of autophagy flux by isopsoralen ameliorates interleukin-1beta-stimulated apoptosis in rat chondrocytes. J. Asian Nat. Prod. Res. 8, 1–14. doi: 10.1080/10286020.2019.1586677
Chen, H. H., Mekkaoui, C., Cho, H., Ngoy, S., Marinelli, B., Waterman, P., et al. (2013). Fluorescence tomography of rapamycin-induced autophagy and cardioprotection in vivo. Circ. Cardiovasc. Imaging 6, 441–447. doi: 10.1161/CIRCIMAGING.112.000074
Cosin-Roger, J., Simmen, S., Melhem, H., Atrott, K., Frey-Wagner, I., Hausmann, M., et al. (2017). Hypoxia ameliorates intestinal inflammation through NLRP3/mTOR downregulation and autophagy activation. Nat. Commun. 8:98. doi: 10.1038/s41467-017-00213-3
Diaz, M., Garcia, C., Sebastiani, G., De Zegher, F., Lopez-Bermejo, A., and Ibanez, L. (2017). Placental and cord blood methylation of genes involved in energy homeostasis: association with fetal growth and neonatal body composition. Diabetes 66, 779–784. doi: 10.2337/db16-0776
Dodson, M., Darley-Usmar, V., and Zhang, J. (2013). Cellular metabolic and autophagic pathways: traffic control by redox signaling. Free Radic. Biol. Med. 63, 207–221. doi: 10.1016/j.freeradbiomed.2013.05.014
Dong, Z., Chu, G., Sima, Y., and Chen, G. (2018). Djhsp90s are crucial regulators during planarian regeneration and tissue homeostasis. Biochem. Biophys. Res. Commun. 498, 723–728. doi: 10.1016/j.bbrc.2018.03.047
DuSablon, A., Parks, J., Whitehurst, K., Estes, H., Chase, R., Vlahos, E., et al. (2017). EphrinA1-Fc attenuates myocardial ischemia/reperfusion injury in mice. PLoS One 12:e0189307. doi: 10.1371/journal.pone.0189307
Foglio, E., Puddighinu, G., Germani, A., Russo, M. A., and Limana, F. (2017). HMGB1 inhibits apoptosis following MI and induces autophagy via mTORC1 inhibition. J. Cell. Physiol. 232, 1135–1143. doi: 10.1002/jcp.25576
Fu, H., Li, X., and Tan, J. (2018). NIPAAm-MMA nanoparticle-encapsulated visnagin ameliorates myocardial ischemia/reperfusion injury through the promotion of autophagy and the inhibition of apoptosis. Oncol. Lett. 15, 4827–4836. doi: 10.3892/ol.2018.7922
Gan, B., Peng, X., Nagy, T., Alcaraz, A., Gu, H., and Guan, J. L. (2006). Role of FIP200 in cardiac and liver development and its regulation of TNFalpha and TSC-mTOR signaling pathways. J. Cell Biol. 175, 121–133. doi: 10.1083/jcb.200604129
Germic, N., Stojkov, D., Oberson, K., Yousefi, S., and Simon, H. U. (2017). Neither eosinophils nor neutrophils require ATG5-dependent autophagy for extracellular DNA trap formation. Immunology 152, 517–525. doi: 10.1111/imm.12790
Ghosh, R., and Pattison, J. S. (2018). Macroautophagy and chaperone-mediated autophagy in heart failure: the known and the unknown. Oxidative Med. Cell. Longev. 2018:8602041. doi: 10.1155/2018/8602041
Gogiraju, R., Hubert, A., Fahrer, J., Straub, B. K., Brandt, M., Wenzel, P., et al. (2019). Endothelial leptin receptor deletion promotes cardiac autophagy and angiogenesis following pressure overload by suppressing Akt/mTOR signaling. Circ. Heart Fail. 12:e005622. doi: 10.1161/CIRCHEARTFAILURE.118.005622
Harnett, M. M., Pineda, M. A., Latre De Late, P., Eason, R. J., Besteiro, S., Harnett, W., et al. (2017). From Christian de Duve to Yoshinori Ohsumi: more to autophagy than just dining at home. Biom. J. 40, 9–22. doi: 10.1016/j.bj.2016.12.004
Kanamori, H., Takemura, G., Goto, K., Maruyama, R., Ono, K., Nagao, K., et al. (2011). Autophagy limits acute myocardial infarction induced by permanent coronary artery occlusion. Am. J. Physiol. Heart Circ. Physiol. 300, H2261–H2271. doi: 10.1152/ajpheart.01056.2010
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., et al. (2016). Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12, 1–222. doi: 10.1080/15548627.2015.1100356
Klopsch, C., Gaebel, R., Lemcke, H., Beyer, M., Vasudevan, P., Fang, H. Y., et al. (2019). Vimentin-induced cardiac mesenchymal stem cells proliferate in the acute ischemic myocardium. Cells Tissues Organs 206, 35–45. doi: 10.1159/000495527
Lambelet, M., Terra, L. F., Fukaya, M., Meyerovich, K., Labriola, L., Cardozo, A. K., et al. (2018). Dysfunctional autophagy following exposure to pro-inflammatory cytokines contributes to pancreatic beta-cell apoptosis. Cell Death Dis. 9:96. doi: 10.1038/s41419-017-0121-5
Li, Q., Dong, Q. T., Yang, Y. J., Tian, X. Q., Jin, C., Huang, P. S., et al. (2016). AMPK-mediated cardioprotection of atorvastatin relates to the reduction of apoptosis and activation of autophagy in infarcted rat hearts. Am. J. Transl. Res. 8, 4160–4171.
Li, Q., Li, N., Cui, H. H., Tian, X. Q., Jin, C., Chen, G. H., et al. (2017). Tongxinluo exerts protective effects via anti-apoptotic and pro-autophagic mechanisms by activating AMPK pathway in infarcted rat hearts. Exp. Physiol. 102, 422–435. doi: 10.1113/EP086192
Li, W., Li, S., Li, Y., Lin, X., Hu, Y., Meng, T., et al. (2018b). Immunofluorescence staining protocols for major autophagy proteins including LC3, P62, and ULK1 in mammalian cells in response to normoxia and hypoxia. Methods Mol. Biol. 1854, 175–185. doi: 10.1007/7651_2018_124
Li, L., Li, S., Wu, M., Chi, C., Hu, D., Cui, Y., et al. (2019). Early diagnostic value of circulating microRNAs in patients with suspected acute myocardial infarction. J. Cell. Physiol. 234, 13649–13658. doi: 10.1002/jcp.28045
Li, Y., Yu, Q. H., Chu, Y., Wu, W. M., Song, J. X., Zhu, X. B., et al. (2018c). Blockage of AKAP12 accelerates angiotensin II (Ang II)-induced cardiac injury in mice by regulating the transforming growth factor beta1 (TGF-beta1) pathway. Biochem. Biophys. Res. Commun. 499, 128–135. doi: 10.1016/j.bbrc.2018.02.200
Liu, X., Deng, Y., Xu, Y., Jin, W., and Li, H. (2018c). MicroRNA-223 protects neonatal rat cardiomyocytes and H9c2 cells from hypoxia-induced apoptosis and excessive autophagy via the Akt/mTOR pathway by targeting PARP-1. J. Mol. Cell. Cardiol. 118, 133–146. doi: 10.1016/j.yjmcc.2018.03.018
Liu, J., Jiang, M., Deng, S., Lu, J., Huang, H., Zhang, Y., et al. (2018b). miR-93-5p-containing exosomes treatment attenuates acute myocardial infarction-induced myocardial damage. Mol. Ther. Nucleic Acids 11, 103–115. doi: 10.1016/j.omtn.2018.01.010
Liu, C. Y., Zhang, Y. H., Li, R. B., Zhou, L. Y., An, T., Zhang, R. C., et al. (2018a). LncRNA CAIF inhibits autophagy and attenuates myocardial infarction by blocking p53-mediated myocardin transcription. Nat. Commun. 9:29. doi: 10.1038/s41467-017-02280-y
Loyer, X., Zlatanova, I., Devue, C., Yin, M., Howangyin, K. Y., Klaihmon, P., et al. (2018). Intra-cardiac release of extracellular vesicles shapes inflammation following myocardial infarction. Circ. Res. 123, 100–106. doi: 10.1161/CIRCRESAHA.117.311326
Lu, J., Pan, S. S., Wang, Q. T., and Yuan, Y. (2018). Alterations of cardiac KATP channels and autophagy contribute in the late cardioprotective phase of exercise preconditioning. Int. Heart J. 59, 1106–1115. doi: 10.1536/ihj.17-003
Ma, H., Guo, R., Yu, L., Zhang, Y., and Ren, J. (2011). Aldehyde dehydrogenase 2 (ALDH2) rescues myocardial ischaemia/reperfusion injury: role of autophagy paradox and toxic aldehyde. Eur. Heart J. 32, 1025–1038. doi: 10.1093/eurheartj/ehq253
Ma, X., Liu, H., Foyil, S. R., Godar, R. J., Weinheimer, C. J., Hill, J. A., et al. (2012). Impaired autophagosome clearance contributes to cardiomyocyte death in ischemia/reperfusion injury. Circulation 125, 3170–3181. doi: 10.1161/CIRCULATIONAHA.111.041814
Mohajeri, M., and Sahebkar, A. (2018). Protective effects of curcumin against doxorubicin-induced toxicity and resistance: a review. Crit. Rev. Oncol. Hematol. 122, 30–51. doi: 10.1016/j.critrevonc.2017.12.005
Ong, S. B., Hernandez-Resendiz, S., Crespo-Avilan, G. E., Mukhametshina, R. T., Kwek, X. Y., Cabrera-Fuentes, H. A., et al. (2018). Inflammation following acute myocardial infarction: multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacol. Ther. 186, 73–87. doi: 10.1016/j.pharmthera.2018.01.001
Paneni, F., Costantino, S., and Cosentino, F. (2015). Metformin and left ventricular remodeling after acute myocardial infarction: molecular mechanisms and clinical implications. G. Ital. Cardiol. 16, 225–231. doi: 10.1714/1848.20186
Pankratz, F., Hohnloser, C., Bemtgen, X., Jaenich, C., Kreuzaler, S., Hoefer, I., et al. (2018). MicroRNA-100 suppresses chronic vascular inflammation by stimulation of endothelial autophagy. Circ. Res. 122, 417–432. doi: 10.1161/CIRCRESAHA.117.311428
Pattison, J. S., Osinska, H., and Robbins, J. (2011). Atg7 induces basal autophagy and rescues autophagic deficiency in CryABR120G cardiomyocytes. Circ. Res. 109, 151–160. doi: 10.1161/CIRCRESAHA.110.237339
Peng, Y., Chen, B., Zhao, J., Peng, Z., Xu, W., and Yu, G. (2019). Effect of intravenous transplantation of hUCB-MSCs on M1/M2 subtype conversion in monocyte/macrophages of AMI mice. Biomed. Pharmacother. 111, 624–630. doi: 10.1016/j.biopha.2018.12.095
Perez-Alvarez, M. J., Villa Gonzalez, M., Benito-Cuesta, I., and Wandosell, F. G. (2018). Role of mTORC1 controlling proteostasis after brain ischemia. Front. Neurosci. 12:60. doi: 10.3389/fnins.2018.00060
Pott, J., Kabat, A. M., and Maloy, K. J. (2018). Intestinal epithelial cell autophagy is required to protect against TNF-induced apoptosis during chronic colitis in mice. Cell Host Microbe 23, 191–202.e194. doi: 10.1016/j.chom.2017.12.017
Przyklenk, K., Undyala, V. V., Wider, J., Sala-Mercado, J. A., Gottlieb, R. A., and Mentzer, R. M. Jr. (2011). Acute induction of autophagy as a novel strategy for cardioprotection: getting to the heart of the matter. Autophagy 7, 432–433.
Qian, J., Ren, X., Wang, X., Zhang, P., Jones, W. K., Molkentin, J. D., et al. (2009). Blockade of Hsp20 phosphorylation exacerbates cardiac ischemia/reperfusion injury by suppressed autophagy and increased cell death. Circ. Res. 105, 1223–1231. doi: 10.1161/CIRCRESAHA.109.200378
Ryter, S. W., Bhatia, D., and Choi, M. E. (2018). Autophagy: a lysosome-dependent process with implications in cellular redox homeostasis and human disease. Antioxid. Redox Signal. 30, 138–159. doi: 10.1089/ars.2018.7518
Sala-Mercado, J. A., Wider, J., Undyala, V. V., Jahania, S., Yoo, W., Mentzer, R. M. Jr., et al. (2010). Profound cardioprotection with chloramphenicol succinate in the swine model of myocardial ischemia-reperfusion injury. Circulation 122, S179–S184. doi: 10.1161/CIRCULATIONAHA.109.928242
Salo, P. P., Vaara, S., Kettunen, J., Pirinen, M., Sarin, A. P., Huikuri, H., et al. (2015). Genetic variants on chromosome 1p13.3 are associated with non-ST elevation myocardial infarction and the expression of DRAM2 in the Finnish population. PLoS One 10:e0140576. doi: 10.1371/journal.pone.0140576
Schwerd, T., Pandey, S., Yang, H. T., Bagola, K., Jameson, E., Jung, J., et al. (2017). Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann–Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn’s disease. Gut 66, 1060–1073. doi: 10.1136/gutjnl-2015-310382
Sciarretta, S., Boppana, V. S., Umapathi, M., Frati, G., and Sadoshima, J. (2015). Boosting autophagy in the diabetic heart: a translational perspective. Cardiovasc. Diagn. Ther. 5, 394–402. doi: 10.3978/j.issn.2223-3652.2015.07.02
Sciarretta, S., Yee, D., Shenoy, V., Nagarajan, N., and Sadoshima, J. (2014). The importance of autophagy in cardioprotection. High Blood Press. Cardiovasc. Prev. 21, 21–28. doi: 10.1007/s40292-013-0029-9
Sciarretta, S., Zhai, P., Shao, D., Maejima, Y., Robbins, J., Volpe, M., et al. (2012). Rheb is a critical regulator of autophagy during myocardial ischemia: pathophysiological implications in obesity and metabolic syndrome. Circulation 125, 1134–1146. doi: 10.1161/CIRCULATIONAHA.111.078212
Sengupta, A., Molkentin, J. D., Paik, J. H., Depinho, R. A., and Yutzey, K. E. (2011). FoxO transcription factors promote cardiomyocyte survival upon induction of oxidative stress. J. Biol. Chem. 286, 7468–7478. doi: 10.1074/jbc.M110.179242
Shoji, K., Yanishi, K., Shiraishi, J., Nakanishi, N., Zen, K., Nakamura, T., et al. (2019). In-stent massive thrombi formation during primary percutaneous coronary intervention in a patient with acute myocardial infarction complicated with essential thrombocythemia. Intern. Med. 58, 1287–1293. doi: 10.2169/internalmedicine.2083-18
Siasos, G., Tsigkou, V., Kosmopoulos, M., Theodosiadis, D., Simantiris, S., Tagkou, N. M., et al. (2018). Mitochondria and cardiovascular diseases-from pathophysiology to treatment. Ann. Transl. Med. 6:256. doi: 10.21037/atm.2018.06.21
Song, H., Yan, C., Tian, X., Zhu, N., Li, Y., Liu, D., et al. (2017). CREG protects from myocardial ischemia/reperfusion injury by regulating myocardial autophagy and apoptosis. Biochim. Biophys. Acta 1863, 1893–1903. doi: 10.1016/j.bbadis.2016.11.015
Tahrir, F. G., Langford, D., Amini, S., Mohseni Ahooyi, T., and Khalili, K. (2019). Mitochondrial quality control in cardiac cells: mechanisms and role in cardiac cell injury and disease. J. Cell. Physiol. 234, 8122–8133. doi: 10.1002/jcp.27597
Tannous, P., Zhu, H., Nemchenko, A., Berry, J. M., Johnstone, J. L., Shelton, J. M., et al. (2008). Intracellular protein aggregation is a proximal trigger of cardiomyocyte autophagy. Circulation 117, 3070–3078. doi: 10.1161/CIRCULATIONAHA.107.763870
Tao, L., Bei, Y., Lin, S., Zhang, H., Zhou, Y., Jiang, J., et al. (2015). Exercise training protects against acute myocardial infarction via improving myocardial energy metabolism and mitochondrial biogenesis. Cell. Physiol. Biochem. 37, 162–175. doi: 10.1159/000430342
Tsuchiya, M., Ogawa, H., Koujin, T., Mori, C., Osakada, H., Kobayashi, S., et al. (2018). p62/SQSTM1 promotes rapid ubiquitin conjugation to target proteins after endosome rupture during xenophagy. FEBS Open Bio 8, 470–480. doi: 10.1002/2211-5463.12385
Wang, L., Li, Y., Ning, N., Wang, J., Yan, Z., Zhang, S., et al. (2018b). Decreased autophagy induced by beta1-adrenoceptor autoantibodies contributes to cardiomyocyte apoptosis. Cell Death Dis. 9:406. doi: 10.1038/s41419-018-0445-9
Wang, B., Nie, J., Wu, L., Hu, Y., Wen, Z., Dong, L., et al. (2018a). AMPKalpha2 protects against the development of heart failure by enhancing mitophagy via PINK1 phosphorylation. Circ. Res. 122, 712–729. doi: 10.1161/CIRCRESAHA.117.312317
Wang, S., Wang, Z., Fan, Q., Guo, J., Galli, G., Du, G., et al. (2016). Ginkgolide K protects the heart against endoplasmic reticulum stress injury by activating the inositol-requiring enzyme 1alpha/X box-binding protein-1 pathway. Br. J. Pharmacol. 173, 2402–2418. doi: 10.1111/bph.13516
Wildenberg, M. E., Koelink, P. J., Diederen, K., Te Velde, A. A., Wolfkamp, S. C., Nuij, V. J., et al. (2017). The ATG16L1 risk allele associated with Crohn’s disease results in a Rac1-dependent defect in dendritic cell migration that is corrected by thiopurines. Mucosal Immunol. 10, 352–360. doi: 10.1038/mi.2016.65
Wu, X., He, L., Chen, F., He, X., Cai, Y., Zhang, G., et al. (2014). Impaired autophagy contributes to adverse cardiac remodeling in acute myocardial infarction. PLoS One 9:e112891. doi: 10.1371/journal.pone.0112891
Wu, X., Zheng, D., Qin, Y., Liu, Z., Zhang, G., Zhu, X., et al. (2017). Nobiletin attenuates adverse cardiac remodeling after acute myocardial infarction in rats via restoring autophagy flux. Biochem. Biophys. Res. Commun. 492, 262–268. doi: 10.1016/j.bbrc.2017.08.064
Xiao, C., Wang, K., Xu, Y., Hu, H., Zhang, N., Wang, Y., et al. (2018). Transplanted mesenchymal stem cells reduce autophagic flux in infarcted hearts via the exosomal transfer of mir-125b. Circ. Res. 123, 564–578. doi: 10.1161/CIRCRESAHA.118.312758
Yang, Y., Li, Y., Chen, X., Cheng, X., Liao, Y., and Yu, X. (2016). Exosomal transfer of miR-30a between cardiomyocytes regulates autophagy after hypoxia. J. Mol. Med. 94, 711–724. doi: 10.1007/s00109-016-1387-2
Zeng, M., Wei, X., Wu, Z., Li, W., Li, B., Zhen, Y., et al. (2013). NF-kappaB-mediated induction of autophagy in cardiac ischemia/reperfusion injury. Biochem. Biophys. Res. Commun. 436, 180–185. doi: 10.1016/j.bbrc.2013.05.070
Zeng, M., Wei, X., Wu, Z., Li, W., Zheng, Y., Li, B., et al. (2016). Simulated ischemia/reperfusion-induced p65-Beclin 1-dependent autophagic cell death in human umbilical vein endothelial cells. Sci. Rep. 6:37448. doi: 10.1038/srep37448
Zhang, Q. Y., Jin, H. F., Chen, S., Chen, Q. H., Tang, C. S., Du, J. B., et al. (2018b). Hydrogen sulfide regulating myocardial structure and function by targeting cardiomyocyte autophagy. Chin. Med. J. 131, 839–844. doi: 10.4103/0366-6999.228249
Zhang, Z., Li, H., Chen, S., Li, Y., Cui, Z., and Ma, J. (2017). Knockdown of MicroRNA-122 protects H9c2 cardiomyocytes from hypoxia-induced apoptosis and promotes autophagy. Med. Sci. Monit. 23, 4284–4290. doi: 10.12659/MSM.902936
Zhang, L., Liu, P., Wen, W., Bai, X., Zhang, Y., Liu, M., et al. (2018a). IL-17A contributes to myocardial ischemic injury by activating NLRP3 inflammasome in macrophages through AMPKalpha/p38MAPK/ERK1/2 signal pathway in mice. Mol. Immunol. 105, 240–250. doi: 10.1016/j.molimm.2018.12.014
Zhang, Y. J., Yang, S. H., Li, M. H., Iqbal, J., Bourantas, C. V., Mi, Q. Y., et al. (2014). Berberine attenuates adverse left ventricular remodeling and cardiac dysfunction after acute myocardial infarction in rats: role of autophagy. Clin. Exp. Pharmacol. Physiol. 41, 995–1002. doi: 10.1111/1440-1681.12309
Zhang, Z., Yang, M., Wang, Y., Wang, L., Jin, Z., Ding, L., et al. (2016). Autophagy regulates the apoptosis of bone marrow-derived mesenchymal stem cells under hypoxic condition via AMP-activated protein kinase/mammalian target of rapamycin pathway. Cell Biol. Int. 40, 671–685. doi: 10.1002/cbin.10604
Zhao, X., Luo, G., Cheng, Y., Yu, W., Chen, R., Xiao, B., et al. (2018a). Compound C induces protective autophagy in human cholangiocarcinoma cells via Akt/mTOR-independent pathway. J. Cell. Biochem. 119, 5538–5550. doi: 10.1002/jcb.26723
Zhao, Y., Shen, X., Na, N., Chu, Z., Su, H., Chao, S., et al. (2018b). mTOR masters monocyte development in bone marrow by decreasing the inhibition of STAT5 on IRF8. Blood 131, 1587–1599. doi: 10.1182/blood-2017-04-777128
Zhao, Z., Zhang, L., Guo, X. D., Cao, L. L., Xue, T. F., Zhao, X. J., et al. (2017). Rosiglitazone exerts an anti-depressive effect in unpredictable chronic mild-stress-induced depressive mice by maintaining essential neuron autophagy and inhibiting excessive astrocytic apoptosis. Front. Mol. Neurosci. 10:293. doi: 10.3389/fnmol.2017.00293
Keywords: acute myocardial infarction, autophagy, cardiomyocyte, ischemia, reperfusion
Citation: Wu D, Zhang K and Hu P (2019) The Role of Autophagy in Acute Myocardial Infarction. Front. Pharmacol. 10:551. doi: 10.3389/fphar.2019.00551
Edited by:Changhua Wang, Wuhan University, China
Reviewed by:Rodrigo Troncoso, Universidad de Chile, Chile
Zully Pedrozo, Universidad de Chile, Chile
Copyright © 2019 Wu, Zhang and Hu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Du Wu, email@example.com